[1]
|
Patterson, K.D. and Pyle, G.F. (1991) The geography and mortality of the 1918 influenza pandemic. Bulletin of the History of Medicine, 65, 4-21.
|
[2]
|
Peiris, J.S., Poon, L.L. and Guan, Y. (2009) Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. Journal of Clinical Virology, 45, 169-173.
doi:10.1016/j.jcv.2009.06.006
|
[3]
|
Souayah, N., et al. (2007) Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine, 25, 5253-5255. doi:10.1016/j.vaccine.2007.03.053
|
[4]
|
Haber, P., et al. (2004) Guillain-Barre syndrome following influenza vaccination. Journal of the American Medical Association, 292, 2478-2481.
doi:10.1001/jama.292.20.2478
|
[5]
|
Nolan, T., et al. (2010) Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trial. Journal of the American Medical Association, 303, 37-46. doi:10.1001/jama.2009.1911
|
[6]
|
Therapeutic Goods Administration (2009) TGA approves vaccine against Pnademic (H1N1) 2009 influenza.
http://www.tga.gov.au/safety/alerts-medicine-pandemic-influenza-090918.htm
|
[7]
|
Department of Health Ageing (2010) The Facts on swine flu. D.o.H. Ageing, Canberra.
http://www.health.gov.au/internet/ministers/publishing.nsf/Content/mr-yr10-nr-nr053.htm
|
[8]
|
National Health and Medical Research Council (2008) The Australian Immunisation Handbook. 9th Edition, National Capital Press, Canberra.
|
[9]
|
Clothier, H.J., et al. (2011) Surveillance of adverse events following immunisation: The model of SAEFVIC, Victoria. Communicable Diseases Intelligence, 35, 294-298.
|
[10]
|
Therapeutic Goods Administration (2010) Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children.
http://www.tga.gov.au/pdf/alerts-medicine-seasonal-flu-101008.pdf
|
[11]
|
Van Buynder, P.G., et al. (2011) Marketing paediatric influenza vaccination: Results of a major metropolitan trial. Influenza and Other Respiratory Viruses, 5, 33-38.
doi:10.1111/j.1750-2659.2010.00167.x
|
[12]
|
Armstrong, P.K., et al. (2011) Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open, 1, e000016.
doi:10.1136/bmjopen-2010-000016
|
[13]
|
Bishop, J. (2010) Seasonal influenza vaccine and young children. D.o.H.a. Ageing, Canberra.
|
[14]
|
Therapeutic Goods Administration (2010) Investigation into Febrile Convulsions in young children after Seasonal Influenza Vaccination. Latest findings and recommendations 30th July 2010. D.o.H.a. Ageing, Canberra.
|
[15]
|
Stokes, B. (2010) Ministerial review into the public health response into the adverse events to the seasonal influenza vaccine. D.o.H. Government of WA, Canberra.
|
[16]
|
Surveillance of adverse events following vaccination in the community. SAEFVIC adverse events reporting, 2007. http://www.saefvic.org.au
|
[17]
|
Australian Bureau of Statistics (2008) Population projections Australia 2006-2101.
http://www.abs.gov.au/ausstats/abs@.nsf/detailspage/3222.02006%20to%202101?opendocument.
|
[18]
|
Australian Institute of Health and Wellbeing (2011) 2009 adult vaccination survey: Summary results. Cat. no. PHE 135. http://www.aihw.gov.au/publication-detail/?id=10737418409
|
[19]
|
Australian Institute of Health and Wellbeing (2010) 2010 pandemic vaccination survey: Summary results. Cat. no. PHE128. http://www.aihw.gov.au/workarea/downloadasset.aspx?id=6442460016
|
[20]
|
Mak, D.B., et al., Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia. Med J Aust, 2010. 193(7): p. 401-4.
|
[21]
|
Mahajan, D., et al., (2010) Annual report: Surveillance of adverse events following immunisation in Australia, 2009. Communicable Diseases Intelligence, 34, 259-276.
|
[22]
|
Vellozzi, C., et al., (2010) Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine, 28, 7248-7255. doi:10.1016/j.vaccine.2010.09.021
|
[23]
|
Liang, X.F., et al. (2011) Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. The New England Journal of Medicine, 364, 638-647.
doi:10.1056/NEJMoa1008553
|
[24]
|
Gosbell, I.B., et al. (2010) Immunisation and multi-dose vials. Vaccine, 28, 6556-6561.
doi:10.1016/j.vaccine.2010.07.052
|
[25]
|
Evans, D., Cauchemez, S. and Hayden, F.G. (2009) “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. The Journal of Infectious Diseases, 200, 321-328. doi:10.1086/603560
|
[26]
|
Hughes, R.A. and D.R. Cornblath, (2005) Guillain-Barre syndrome. Lancet, 366, 1653-1666.
doi:10.1016/S0140-6736(05)67665-9
|
[27]
|
Department of Health Ageing (2011) Review of Australia’s health sector response to pandemic (H1N1) 2009, lessons identified. D.o.H.a, Canberra.
|
[28]
|
Crawford, N.W. (2011) GBS active: Targeted active surveillance for Guillain-Barre syndrome following the introduction of H1N1 vaccines in victoria, Australia. World Society of Paediatric Infectious Diseases Conference, Melbourne, 16-19 November 2011.
|
[29]
|
Blyth, C.C., et al. (2011) Trivalent influenza vaccine and febrile adverse events in Australia, 2010: Clinical features and potential mechanisms. Vaccine, 29, 5107-5113.
doi:10.1016/j.vaccine.2011.05.054
|
[30]
|
Horvath, J. (2010) Review of the management of adverse events associated with Panvax and Fluvax. D.o.H. Ageing, Canberra.
|
[31]
|
Kelly, H.A., et al. (2011) Adverse events associated with 2010 CSL and other inactivated influenza vaccines. Medical Journal of Australia, 195, 318-320.
doi:10.5694/mja11.10941
|
[32]
|
Department of Health Ageing (2010) Summary of ATAGI recommendations for selection of seasonal influenza vaccine for children >6 months to <5 years, adults and other risk groups.
http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/2723D54E78BF5739CA2576400027E1E9/$File/atagi-TIV-30jul10.pdf
|
[33]
|
Centers for Disease Control and Prevention (2010) Media statement: ACIP recommendation for use of CSL influenza vaccine.
http://www.cdc.gov/media/pressrel/2010/s100806.htm
|